Free Trial
NASDAQ:EPIX

ESSA Pharma Q3 2025 Earnings Report

ESSA Pharma logo
$0.24 0.00 (-1.59%)
As of 10:25 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ESSA Pharma EPS Results

Actual EPS
-$0.09
Consensus EPS
-$0.17
Beat/Miss
Beat by +$0.08
One Year Ago EPS
N/A

ESSA Pharma Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ESSA Pharma Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Wednesday, August 13, 2025
Conference Call Time
4:00PM ET

Earnings Documents

ESSA Pharma Earnings Headlines

What's the Best Way to Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.tc pixel
Essa Pharma trading halted, news pending
See More ESSA Pharma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ESSA Pharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ESSA Pharma and other key companies, straight to your email.

About ESSA Pharma

ESSA Pharma (NASDAQ:EPIX), a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

View ESSA Pharma Profile

More Earnings Resources from MarketBeat